Tenaya Therapeutics (TNYA) Earnings Date & Reports
Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease... Show more
Get AI intraday alerts
A.I. Advisor
published Earnings
TNYA is expected to report earnings to rise 25.00% to -10 cents per share on March 23
Q4'26
Est.
$-0.10
Q3'26
Beat
by $0.02
Q2'26
Missed
by $0.14
Q1'26
Est.
$-0.09
Q4'25
Est.
$-0.12
The last earnings report on November 04 showed earnings per share of -7 cents, beating the estimate of -10 cents. With 757.28K shares outstanding, the current market capitalization sits at 80.77M.